Context Therapeutics Stock Price History

CNTX Stock  USD 1.02  0.07  6.42%   
If you're considering investing in Context Stock, it is important to understand the factors that can impact its price. As of today, the current price of Context Therapeutics stands at 1.02, as last reported on the 22nd of December, with the highest price reaching 1.11 and the lowest price hitting 0.96 during the day. Context Therapeutics secures Sharpe Ratio (or Efficiency) of -0.22, which signifies that the company had a -0.22% return per unit of risk over the last 3 months. Context Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Context Therapeutics' Mean Deviation of 3.43, standard deviation of 4.52, and Risk Adjusted Performance of (0.18) to double-check the risk estimate we provide.
  
At this time, Context Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 83.9 M in 2024, whereas Preferred Stock Total Equity is likely to drop slightly above 130.1 M in 2024. . At this time, Context Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 1.60 in 2024, whereas Price Earnings Ratio is likely to drop (0.79) in 2024. Context Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2222

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCNTX

Estimated Market Risk

 4.47
  actual daily
39
61% of assets are more volatile

Expected Return

 -0.99
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.22
  actual daily
0
Most of other assets perform better
Based on monthly moving average Context Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Context Therapeutics by adding Context Therapeutics to a well-diversified portfolio.
Price Book
0.9212
Book Value
0.744
Enterprise Value
-7.3 M
Enterprise Value Ebitda
1.5966
Shares Float
39.1 M

Context Therapeutics Stock Price History Chart

There are several ways to analyze Context Stock price data. The simplest method is using a basic Context candlestick price chart, which shows Context Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 24, 20242.35
Lowest PriceDecember 20, 20241.02

Context Therapeutics December 22, 2024 Stock Price Synopsis

Various analyses of Context Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Context Stock. It can be used to describe the percentage change in the price of Context Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Context Stock.
Context Therapeutics Price Daily Balance Of Power(0.47)
Context Therapeutics Price Action Indicator(0.05)
Context Therapeutics Price Rate Of Daily Change 0.94 

Context Therapeutics December 22, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Context Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Context Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Context Stock and then apply it to test your longer-term investment strategies against Context.

Context Stock Price History Data

The price series of Context Therapeutics for the period between Mon, Sep 23, 2024 and Sun, Dec 22, 2024 has a statistical range of 1.33 with a coefficient of variation of 18.01. The prices are distributed with arithmetic mean of 1.82. The median price for the last 90 days is 1.9.
OpenHighLowCloseVolume
12/22/2024
 1.06  1.11  0.96  1.02 
12/20/2024 1.06  1.11  0.96  1.02  339,733 
12/19/2024 1.23  1.23  1.08  1.09  264,195 
12/18/2024 1.32  1.33  1.18  1.22  164,067 
12/17/2024 1.35  1.39  1.17  1.29  342,629 
12/16/2024 1.39  1.39  1.27  1.36  361,681 
12/13/2024 1.45  1.47  1.37  1.39  239,182 
12/12/2024 1.50  1.52  1.40  1.44  352,529 
12/11/2024 1.56  1.61  1.49  1.50  230,239 
12/10/2024 1.50  1.56  1.48  1.56  180,542 
12/09/2024 1.50  1.53  1.48  1.50  158,162 
12/06/2024 1.50  1.53  1.43  1.50  188,295 
12/05/2024 1.52  1.52  1.48  1.50  166,157 
12/04/2024 1.51  1.57  1.48  1.51  48,747 
12/03/2024 1.52  1.56  1.49  1.51  157,467 
12/02/2024 1.50  1.65  1.48  1.56  90,610 
11/29/2024 1.51  1.55  1.50  1.52  45,803 
11/27/2024 1.47  1.55  1.47  1.50  70,644 
11/26/2024 1.45  1.53  1.42  1.47  161,403 
11/25/2024 1.39  1.55  1.39  1.46  331,550 
11/22/2024 1.35  1.43  1.27  1.39  790,047 
11/21/2024 1.53  1.58  1.32  1.50  586,570 
11/20/2024 1.65  1.67  1.51  1.63  129,005 
11/19/2024 1.61  1.74  1.61  1.65  151,175 
11/18/2024 1.84  1.84  1.56  1.68  311,441 
11/15/2024 1.84  1.89  1.78  1.84  133,350 
11/14/2024 1.97  1.97  1.84  1.90  142,779 
11/13/2024 2.07  2.10  1.96  1.97  80,553 
11/12/2024 2.03  2.10  1.94  2.05  217,134 
11/11/2024 1.95  2.07  1.93  2.04  129,122 
11/08/2024 2.06  2.09  1.90  1.95  338,993 
11/07/2024 2.25  2.25  2.07  2.09  116,458 
11/06/2024 2.32  2.32  2.17  2.22  98,643 
11/05/2024 2.23  2.26  2.14  2.21  99,991 
11/04/2024 2.29  2.33  2.20  2.23  83,982 
11/01/2024 2.23  2.30  2.19  2.27  126,647 
10/31/2024 2.19  2.26  2.13  2.18  92,422 
10/30/2024 2.27  2.28  2.13  2.17  170,633 
10/29/2024 2.33  2.38  2.22  2.24  257,942 
10/28/2024 2.40  2.40  2.25  2.30  400,176 
10/25/2024 2.38  2.38  2.26  2.34  266,038 
10/24/2024 2.28  2.46  2.22  2.35  853,720 
10/23/2024 2.49  2.59  2.17  2.23  2,417,867 
10/22/2024 2.03  2.15  1.99  2.00  264,618 
10/21/2024 2.06  2.08  2.03  2.06  49,277 
10/18/2024 2.01  2.06  1.97  2.04  36,499 
10/17/2024 2.02  2.09  1.98  2.01  83,776 
10/16/2024 2.00  2.08  1.99  2.05  86,041 
10/15/2024 2.00  2.09  1.94  1.95  156,614 
10/14/2024 1.97  2.06  1.96  1.99  83,045 
10/11/2024 1.67  1.99  1.67  1.96  83,419 
10/10/2024 1.85  1.85  1.65  1.71  168,992 
10/09/2024 1.89  1.89  1.80  1.84  17,249 
10/08/2024 1.82  1.90  1.82  1.86  32,911 
10/07/2024 1.91  1.91  1.77  1.83  57,303 
10/04/2024 1.98  2.01  1.89  1.92  1,191,286 
10/03/2024 1.90  2.03  1.88  1.98  544,162 
10/02/2024 1.81  1.96  1.81  1.89  80,493 
10/01/2024 1.97  2.04  1.82  1.86  565,023 
09/30/2024 1.85  2.01  1.85  1.96  144,099 
09/27/2024 1.87  1.90  1.73  1.86  2,651,043 

About Context Therapeutics Stock history

Context Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Context is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Context Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Context Therapeutics stock prices may prove useful in developing a viable investing in Context Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding18.4 M15.4 M
Net Loss-12 M-12.6 M

Context Therapeutics Stock Technical Analysis

Context Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Context Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Context Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module

Context Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Context Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Context Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Context to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Context Stock Analysis

When running Context Therapeutics' price analysis, check to measure Context Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Context Therapeutics is operating at the current time. Most of Context Therapeutics' value examination focuses on studying past and present price action to predict the probability of Context Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Context Therapeutics' price. Additionally, you may evaluate how the addition of Context Therapeutics to your portfolios can decrease your overall portfolio volatility.